In terms of the potential applications of T3 in disease, previous reports demonstrate that knockdown of CLK2 inhibits growth of breast tumors with overexpresseed CLK2 in cell and animal models of the disease, correlating with splicing alterations12. Here, CLK2 is linked to breast neoplasm.